Drugplain

Rilpivirine 25 mg/1

Rilpivirine · TABLET, FILM COATED · Somerset Therapeutics, LLC

No Recall History
Plain English

Rilpivirine is a prescription oral tablet used to treat HIV infection as part of combination antiretroviral therapy. It belongs to a class of HIV medications that work by blocking reverse transcriptase, an enzyme the virus needs to replicate.

Key Facts

Brand Name
Rilpivirine
Generic Name
Rilpivirine
NDC Code (Product)
70069-848
Manufacturer
Somerset Therapeutics, LLC
Strength
25 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
ANDA218798
Marketing Start
01/30/2026

Recall History

No Recall History

Frequently Asked Questions

What is Rilpivirine used for?

Rilpivirine is a prescription oral tablet used to treat HIV infection as part of combination antiretroviral therapy. It belongs to a class of HIV medications that work by blocking reverse transcriptase, an enzyme the virus needs to replicate.

Is Rilpivirine a controlled substance?

Rilpivirine is not classified as a controlled substance by the DEA.

What is the generic name for Rilpivirine?

The generic name for Rilpivirine is Rilpivirine. There are 2 other brand versions of Rilpivirine.

What is the NDC code for Rilpivirine 25 mg/1?

The NDC (National Drug Code) for Rilpivirine 25 mg/1 is 70069-848, listed by Somerset Therapeutics, LLC.

Product NDC

70069-848

Package NDC

70069-848-30

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)